Treatment for sellar region tumors with unruptured brain aneurysm
Part of Brain & nervous system, Cancer, Genetic & congenital clinical trials.
This trial is for people who have both a tumor in the sellar region (an area near the center of the brain) and an unruptured brain aneurysm (a bulging blood vessel that hasn't burst). It tests different treatments, like surgery or observation, to see what works best. If you have these conditions and haven't had treatment yet, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a tumor in the sellar region, confirmed by an MRI.
- You also have an unruptured brain aneurysm, confirmed by a CTA or DSA scan.
- You haven't had surgery or other treatment for the tumor or the aneurysm before.
- You are healthy enough to undergo surgery or other procedures.
- You or your legal guardian agree to join the trial and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two special food products (Salovum and SPC Flakes) can help reduce brain swelling caused by tumors. If you have a brain tumor with swelling and are already on steroids, you may be able to join.
This trial tests a new anti-fog drainage device used during endoscopic pituitary tumor surgery. The device may help keep the surgeon's view clear and improve drainage after surgery.
This study is collecting information from people with rare diseases of the pituitary gland or nearby areas. It aims to better understand these conditions and improve care.
This study tests a new type of absorbable (dissolvable) support plate used during minimally invasive surgery to remove tumors in the pituitary gland area. The plate helps support the surgical site as it heals. Researchers want to see if this new plate works safely and effectively compared to standard approaches.
This trial studies pituitary tumors that have spread into a nearby area called the cavernous sinus. It aims to learn more about these tumors by looking at donated tissue samples and health information to improve future care.
This Phase 3 trial studies a radioactive liquid called yttrium colloid (90Y) given around the time of surgery for cyst-like tumors near the pituitary gland. The goal is to see if it can improve treatment when you need an operation.
Hear when a new Craniopharyngioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.